Wikidata

(Q81230426)

English

Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial

scientific article published on 19 September 2005

In more languages

Statements

title
Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16169561
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16169561%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020
author name string
EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) Study Group and the University of British Columbia MS/MRI Research Group
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16169561
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16169561%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 January 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q81230426&oldid=1782362102"